A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.